We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B).
- Authors
Tsubata, Yukari; Watanabe, Kana; Saito, Ryota; Nakamura, Atsushi; Yoshioka, Hiroshige; Morita, Mami; Honda, Ryoichi; Kanaji, Nobuhiro; Oizumi, Satoshi; Jingu, Daisuke; Nakagawa, Taku; Nakazawa, Kensuke; Mouri, Atsuto; Takeuchi, Susumu; Furuya, Naoki; Akazawa, Yuki; Miura, Kiyotaka; Ichihara, Eiki; Maemondo, Makoto; Morita, Satoshi
- Subjects
NON-small-cell lung carcinoma; CANCER invasiveness; OSIMERTINIB; KINASE inhibitors; THERAPEUTICS
- Publication
International Journal of Clinical Oncology, 2022, Vol 27, Issue 4, p823
- ISSN
1341-9625
- Publication type
Correction Notice
- DOI
10.1007/s10147-022-02118-8